AARTIDRUGS — Aarti Drugs Balance Sheet
0.000.00%
- IN₹36.02bn
- IN₹41.52bn
- IN₹23.87bn
- 96
- 27
- 79
- 80
Annual balance sheet for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 215 | 342 | 197 | 198 | 216 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6,193 | 8,325 | 8,659 | 7,052 | 7,624 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10,568 | 13,934 | 14,918 | 13,207 | 13,384 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,844 | 7,665 | 8,622 | 10,351 | 11,331 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 17,660 | 22,080 | 24,214 | 24,324 | 25,747 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,954 | 9,401 | 9,495 | 7,955 | 8,370 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 8,526 | 11,716 | 12,290 | 11,508 | 12,057 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9,134 | 10,364 | 11,924 | 12,815 | 13,690 |
| Total Liabilities & Shareholders' Equity | 17,660 | 22,080 | 24,214 | 24,324 | 25,747 |
| Total Common Shares Outstanding |